Viewing Study NCT00553618


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-08 @ 3:31 AM
Study NCT ID: NCT00553618
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2021-10-29
First Post: 2007-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Sponsor: University of Louisville
Organization: